Can autism be helped by gluten-free, casein-free diets?

    Researchedby:
    Last Updated: October 13, 2024

    Gluten and casein are two food components thought to exacerbate autism spectrum disorder (ASD) symptoms. But when diets free of gluten and casein are analyzed in rigorously controlled trials, no improvements are seen in ASD behavior outcomes.

    Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by impaired social communication and repetitive behavior patterns. While the exact pathology of ASD is unknown, there may be a connection between diet and ASD behavioral symptoms.

    Many dietary supplements have been investigated as potential treatments, including omega-3 fatty acids,[1] melatonin,[2] vitamin-d,[3] and a combination of vitamin-b6 and magnesium;[4] but the gluten-free and casein-free (GFCF) diet has become one of the more popular interventions among parents with ASD children.

    Survey have shown that anywhere from 20% to 70% of respondents[5] have tried a GFCF diet. Parents often report symptom improvement when placing their children on this diet,[6] but what do results from randomized controlled trials (RCTs) tell us?

    Many families try decreasing autism spectrum disorder (ASD) symptoms with a gluten-free, casein-free (GFCF) diet. Several trials have been conducted to examine this connection.

    What is the theory behind the GFCF diet?

    The opioid-excess theory of ASD has long been a popular hypothesis for explaining how a GFCF diet may alleviate ASD behavioral symptoms.[7] It has three main components:

    1. The incomplete breakdown of the proteins making up gluten and casein can form excess opioid peptides.

    2. These peptides can enter the body through an abnormally permeable intestinal border, which is speculated to be more common in people with ASD.[8]

    3. If produced in sufficient quantities, these peptides could theoretically cross the blood–brain barrier and interfere with normal brain development.[8]

    image

    This hypothesis, however, is being disputed. Some studies did report greater gut permeability in people with ASD,[9][10] but others saw no difference.[11] Moreover, highly sensitive measurement techniques consistently failed to find detectable concentrations of opioid peptides in the urine samples of patients with ASD.[12][13] If significant amounts of opioid peptides were making it past the gut and into the bloodstream, urine tests should reveal their high levels as the body worked to eliminate them.

    According to the opioid-excess theory, the incomplete breakdown of gluten or casein (two proteins) can form opioid peptides that may exacerbate ASD symptoms. However, the literature does not consistently support this hypothesis.

    What do GFCF studies show?

    Since the 1970s, more than 30 trials have tried to ascertain the role a GFCF diet could play in ASD therapy, but many suffered from poor methodological quality.[5][14]

    The trials often

    • Were short in duration.
    • Had small sample sizes.
    • Lacked a control group.
    • Were single-blinded or not blinded at all.
    • Performed no power calculation.

    Moreover, changes in behavior were usually reported only by the parents, yet in most trials, the parents knew which group (placebo or GFCF) their child was in. This knowledge introduced possible bias into the studies, since the parents who believed that the GFCF diet would benefit their child were more likely to report positive results even if there were none. Unconscious bias such as this can lead to false positives in a study’s findings.

    To reduce the risk of bias, we’ll examine the most rigorously controlled GFCF trials currently available: those that are double-blinded, randomized, and placebo-controlled. At present, five such trials have been conducted.

    2006 Study

    The gluten-free, casein-free diet in autism: results of a preliminary double-blind clinical trial.[15]

    image

    Standard assessment questionnaires were administered, such as the Childhood Autism Rating Scale (CARS) and the Ecological Communication Orientation Scale (ECOS). Both scales monitor the frequency of behavioral patterns, such as social initiating, social responding, intelligible words spoken, and non-speech vocalizations.

    Additionally, research assistants videotaped the child interacting with their primary caretaking parent. Two independent coders, who were blinded to the dietary treatment status of the child, rated each taped assessment. No significant differences were observed for any of the behavioral endpoints measured between the GFCF diet and the control diet.

    2007 Study

    The gluten- and casein-free diet and autism: communication outcomes from a preliminary double-blind clinical trial.[16]

    image

    This study is a retrospective analysis of the “2006 Study” above. Its authors sought to perform a more in-depth analysis of the verbal and nonverbal communication outcomes than the one mediated by the ECOS scale, used in the original study. With this aim in mind, they re-evaluated the existing videotapes of parent-and-child interactions, with a focus on verbal communication. Again, however, no significant changes were observed between the GFCF diet and the control diet.

    2014 Study

    Are “leaky gut” and behavior associated with gluten- and dairy-containing diet in children with autism spectrum disorders?[17]

    image

    For the first 2 weeks, all participants followed a GFCF diet. For the remaining 4 weeks, they were randomized to the intervention group (brown rice flour) or the control group (gluten powder and non-fat dried milk). Blinded to the group a child was in, parents and investigators assessed hyperactivity, irritability, and inattention. No significant behavioral differences were observed between groups.

    2015 Study

    Gluten and casein supplementation does not increase symptoms in children with autism spectrum disorder.[18]

    image

    Researchers used the Approach Withdrawal Problems Composite (AWPC) subtest of the Pervasive Developmental Disorder Behavior Inventory (PDDBI) to monitory maladaptive behavior before and after supplementation. In both groups, the AWPC score decreased significantly after supplementation. But the researchers noted that “the change in the degree of maladaptive behavior was not significantly different between the two groups (p = 0.971)” (emphasis added).

    2016 Study

    The gluten-free/casein-free diet: a double-blind challenge trial in children with autism.[19]

    image

    The main conclusion of this study was that the GFCF diet did not change measures of “physiologic function, behavioral disturbance (sleep disruption and over-activity), or ASD-related behaviors”. The researchers also examined the children’s individual data to see if any individual results were being masked by the overall group result, but again found no clear pattern suggesting that the dietary challenge had had any effect, positive or negative, on any of the behavioral outcomes measured. A subset of children actually experienced fewer negative social relationship symptoms on the days gluten and casein were co-administered, but this trend never reached statistical significance.

    Conclusion

    Five double-blind, randomized, placebo-controlled trials examining a total of 89 children have found that a GFCF diet did not improve ASD behavior symptoms.


    image

    Is GFCF the best therapy for ASD? Unlikely.

    Two recent systematic reviews[20][21] and a consensus report by the American Academy of Pediatrics[22] have concluded that cutting out gluten and casein isn’t likely to help in the treatment of ASD.

    Anecdotal reports of improvement could be due to casein- and gluten-free diets accompanying some other treatment or some healthy lifestyle habits. The potential benefits of other, more comprehensive diet changes have not been rigorously tested.

    Given the current lack of evidence that a GFCF diet benefits people with ASD, emphasis on behavioral therapies is likely to provide greater benefit.[23][24]

    A GFCF diet is unlikely, at least one its own, to improve the behavior of children with ASD. Time, energy, and resources may be better spent pursuing other treatment options.

    References

    1. ^James S, Montgomery P, Williams KOmega-3 fatty acids supplementation for autism spectrum disorders (ASD)Cochrane Database Syst Rev.(2011 Nov 9)
    2. ^Rossignol DA, Frye REMelatonin in autism spectrum disorders: a systematic review and meta-analysisDev Med Child Neurol.(2011 Sep)
    3. ^Mazahery H, Camargo CA Jr, Conlon C, Beck KL, Kruger MC, von Hurst PRVitamin D and Autism Spectrum Disorder: A Literature ReviewNutrients.(2016 Apr 21)
    4. ^Nye C, Brice ACombined vitamin B6-magnesium treatment in autism spectrum disorderCochrane Database Syst Rev.(2005 Oct 19)
    5. ^Marí-Bauset S, Zazpe I, Mari-Sanchis A, Llopis-González A, Morales-Suárez-Varela MEvidence of the gluten-free and casein-free diet in autism spectrum disorders: a systematic reviewJ Child Neurol.(2014 Dec)
    6. ^Winburn E, Charlton J, McConachie H, McColl E, Parr J, O'Hare A, Baird G, Gringras P, Wilson DC, Adamson A, Adams S, Le Couteur AParents' and child health professionals' attitudes towards dietary interventions for children with autism spectrum disordersJ Autism Dev Disord.(2014 Apr)
    7. ^Panksepp JA neurochemical theory of autismTrends in Neurosciences.(1979)
    8. ^Shattock P, Whiteley PBiochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical interventionExpert Opin Ther Targets.(2002 Apr)
    9. ^van De Sande MM, van Buul VJ, Brouns FJAutism and nutrition: the role of the gut-brain axisNutr Res Rev.(2014 Dec)
    10. ^de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, Carteni M, De Rosa M, Francavilla R, Riegler G, Militerni R, Bravaccio CAlterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relativesJ Pediatr Gastroenterol Nutr.(2010 Oct)
    11. ^Dalton N, Chandler S, Turner C, Charman T, Pickles A, Loucas T, Simonoff E, Sullivan P, Baird GGut permeability in autism spectrum disordersAutism Res.(2014 Jun)
    12. ^Dettmer K, Hanna D, Whetstone P, Hansen R, Hammock BDAutism and urinary exogenous neuropeptides: development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theoryAnal Bioanal Chem.(2007 Aug)
    13. ^Cass H, Gringras P, March J, McKendrick I, O'Hare AE, Owen L, Pollin CAbsence of urinary opioid peptides in children with autismArch Dis Child.(2008 Sep)
    14. ^Millward C, Ferriter M, Calver S, Connell-Jones GGluten- and casein-free diets for autistic spectrum disorderCochrane Database Syst Rev.(2008 Apr 16)
    15. ^Elder JH, Shankar M, Shuster J, Theriaque D, Burns S, Sherrill LThe gluten-free, casein-free diet in autism: results of a preliminary double blind clinical trialJ Autism Dev Disord.(2006 Apr)
    16. ^Seung, H., Rogalski, Y., Shankar, M., & Elder, J.The gluten- and casein-free diet and autism: Communication outcomes from a preliminary double-blind clinical trial.Journal of Medical Speech-Language Pathology.(2007)
    17. ^Navarro F, Pearson DA, Fatheree N, Mansour R, Hashmi SS, Rhoads JMAre 'leaky gut' and behavior associated with gluten and dairy containing diet in children with autism spectrum disorders?Nutr Neurosci.(2015 May)
    18. ^Pusponegoro HD, Ismael S, Firmansyah A, Sastroasmoro S, Vandenplas YGluten and casein supplementation does not increase symptoms in children with autism spectrum disorderActa Paediatr.(2015 Nov)
    19. ^Hyman SL, Stewart PA, Foley J, Cain U, Peck R, Morris DD, Wang H, Smith TThe Gluten-Free/Casein-Free Diet: A Double-Blind Challenge Trial in Children with AutismJ Autism Dev Disord.(2016 Jan)
    20. ^Piwowarczyk A, Horvath A, Łukasik J, Pisula E, Szajewska HGluten- and casein-free diet and autism spectrum disorders in children: a systematic reviewEur J Nutr.(2018 Mar)
    21. ^Sathe N, Andrews JC, McPheeters ML, Warren ZENutritional and Dietary Interventions for Autism Spectrum Disorder: A Systematic ReviewPediatrics.(2017 Jun)
    22. ^Buie T, Campbell DB, Fuchs GJ 3rd, Furuta GT, Levy J, Vandewater J, Whitaker AH, Atkins D, Bauman ML, Beaudet AL, Carr EG, Gershon MD, Hyman SL, Jirapinyo P, Jyonouchi H, Kooros K, Kushak R, Levitt P, Levy SE, Lewis JD, Murray KF, Natowicz MR, Sabra A, Wershil BK, Weston SC, Zeltzer L, Winter HEvaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus reportPediatrics.(2010 Jan)
    23. ^Vasa RA, Mazurek MO, Mahajan R, Bennett AE, Bernal MP, Nozzolillo AA, Arnold LE, Coury DLAssessment and Treatment of Anxiety in Youth With Autism Spectrum DisordersPediatrics.(2016 Feb)
    24. ^Zwaigenbaum L, Bauman ML, Choueiri R, Kasari C, Carter A, Granpeesheh D, Mailloux Z, Smith Roley S, Wagner S, Fein D, Pierce K, Buie T, Davis PA, Newschaffer C, Robins D, Wetherby A, Stone WL, Yirmiya N, Estes A, Hansen RL, McPartland JC, Natowicz MREarly Intervention for Children With Autism Spectrum Disorder Under 3 Years of Age: Recommendations for Practice and ResearchPediatrics.(2015 Oct)